Related Experiment Video
Updated: Jan 29, 2026
02:34
Author Spotlight: Efficacy of Auricular Pressure Bean Therapy in Reducing Wheezing Symptoms
Published on: May 10, 2024
1.9K
Antioxidants and Chronic Obstructive Pulmonary Disease.
Félix-Antoine Vézina1, André M Cantin1,2
1Respiratory Division, Department of Medicine, Faculty of Medicine and Health Sciences, University of Sherbrooke, Quebec Canada.
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)
|February 7, 2019
Summary
Antioxidants show promise for chronic obstructive pulmonary disease (COPD) therapy by combating oxidative stress from cigarette smoke. While animal studies are positive, more clinical evidence is needed to confirm antioxidant benefits for COPD patients.
Area of Science:
- Pulmonary Medicine
- Oxidative Stress Research
Background:
- Chronic obstructive pulmonary disease (COPD) is strongly linked to oxidative stress induced by cigarette smoke.
- Cigarette smoke generates oxidants that cause cell damage and inflammation, involving macrophages and neutrophils via the NADPH oxidase complex.
- Inflammation and oxidative stress markers persist in COPD patients even after smoking cessation.
Purpose of the Study:
- To review pre-clinical and clinical evidence on the role of antioxidants in COPD therapy.
- To evaluate the potential of antioxidants in managing COPD-related inflammation and oxidative damage.
Main Methods:
- Review of animal models of cigarette smoke-induced lung injury.
- Examination of pre-clinical studies on antioxidant interventions in COPD.
- Analysis of available clinical trial data for antioxidant efficacy in COPD patients.
Main Results:
- Animal models suggest antioxidants can mitigate inflammation and morphological changes in COPD.
- Clinical evidence supporting antioxidant benefits in COPD patients is currently limited.
- Oxidants play a dual role, contributing to damage but also pathogen defense and inflammation resolution.
Conclusions:
- Antioxidants present a potential therapeutic strategy for COPD, targeting key pathological mechanisms.
- Further robust clinical trials are necessary to establish the efficacy and safety of antioxidants for COPD treatment.
- Understanding the complex role of oxidants is crucial for developing effective antioxidant therapies.
Related Concept Videos
01:24Chronic Obstructive Pulmonary Disease
2.5K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.5K
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
4.4K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
4.4K
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
3.7K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
3.7K
01:29Chronic Obstructive Pulmonary Disease-V: Management
3.2K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
3.2K
01:30Chronic Obstructive Pulmonary Disease-V: Nursing Management
5.1K
Nursing management of Chronic Obstructive Pulmonary Disease (COPD) is crucial for providing thorough care and support to patients. Nurses play an integral role in this process through detailed assessment, careful planning, targeted interventions, and ongoing evaluation. Here's an overview of the critical steps in nursing management for COPD.
Assessment
Assessment
5.1K
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
3.7K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
3.7K